Please let this be accurate.
Courtesy of NYT:
The drug maker Pfizer announced on Monday that an early analysis of its coronavirus vaccine trial suggested the vaccine was robustly effective in preventing Covid-19, a promising development as the world has waited anxiously for any positive news about a pandemic that has killed more than 1.2 million people.
Pfizer, which developed the vaccine with the German drugmaker BioNTech, released only sparse details from its clinical trial, based on the first formal review of the data by an outside panel of experts.
The company said that the analysis found that the vaccine was more than 90 percent effective in preventing the disease among trial volunteers who had no evidence of prior coronavirus infection. If the results hold up, that level of protection would put it on par with highly effective childhood vaccines for diseases such as measles. No serious safety concerns have been observed, the company said.
Pfizer plans to ask the Food and Drug Administration for emergency authorization of the two-dose vaccine later this month, after it has collected the recommended two months of safety data. By the end of the year it will have manufactured enough doses to immunize 15 to 20 million people, company executives have said.
We are being cautioned that there is still a lot more testing to be done and questions to be answered, such as how long will the vaccine protect us?
Still, this is some good news that gives some hope that we are nearing the end of this long dark tunnel.
As you probably predicted Mike Pence tried to give credit for this breakthrough to the Trump administration citing some kind of partnership, but the facts are that Pfizer refused to work with the White House in the development of this vaccine in order to keep the stupid out of their research.